News
-
-
-
COMMUNIQUÉ DE PRESSE
ASTCT Applauds FDA Approval of Axatilimab-Csfr for the Treatment of Chronic Graft-Versus-Host Disease (cGVHD)
ASTCT applauds FDA approval of Niktimvo by Incyte Corporation for cGVHD treatment. Study confirms efficacy and potential benefits for patients. ASTCT remains committed to advancing transplantation field -
-
-
COMMUNIQUÉ DE PRESSE
American Society for Transplantation and Cellular Therapy Applauds FDA Approval of TECELRA(R) for Synovial Sarcoma Treatment
The FDA's accelerated approval of TECELRA marks a milestone in cancer treatment. ASTCT supports this advance in cellular therapy for synovial sarcoma patients -
-
-
-
